Showing results (1-10 of 776) with videos related to
Sort By:
Pageof 78
Drugs & Aging|January 1, 1996
Optimising thrombolytic therapy in elderly patients with acute myocardial infarctionM Verstraete, D CollenJournal of the American College of Cardiology|December 1, 1986
Pharmacology of thrombolytic drugsM Verstraete, D CollenThe Journal of Clinical Investigation|August 1, 1971
Metabolism of fibrinogen in cirrhosis of the liverG N Tytgat, D Collen, M VerstraeteThe Journal of Clinical Investigation|February 1, 1983
Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administrationD Collen, J M Stassen, M VerstraeteBritish Journal of Haematology|May 1, 1978
Inhibition of plasmin by antithrombin-heparin complex. II. During thrombolytic therapy in manD Collen, N Semeraro, P Telesforo, et al.European Journal of Clinical Investigation|June 1, 1978
Turnover of radiolabelled plasminogen and prothrombin in cirrhosis of the liverD Collen, J Rouvier, D A Chamone, et al.Circulation|October 1, 1986
Synergism of thrombolytic agents in vivoD Collen, J M Stassen, D C Stump, et al.The Journal of Clinical Investigation|June 1, 1972
Metabolism of plasminogen in healthy subjects: effect of tranexamic acidD Collen, G Tytgat, H Claeys, et al.Thrombosis and Haemostasis|August 20, 1986
Pharmacokinetics and effects on fibrinolytic and coagulation parameters of two doses of recombinant tissue-type plasminogen activator in healthy volunteersM Verstraete, C A Su, P Tanswell, et al.Pageof 78